Bernhard Sakmann, M.D.

Bernhard Sakmann, M.D., is a Senior Managing Director in Investment Banking at Leerink Partners covering the Medical Technology and Life Science Tools and Diagnostics sectors.

Prior to joining the Firm in 2024, Dr. Sakmann was a Senior Managing Director at Evercore, where he provided strategic and financial advice to life science companies with a focus on medical technology and life science tools and diagnostics. Prior to that, Dr. Sakmann spent over a decade in healthcare investment banking and in management consulting with Citigroup, Lehman Brothers and Oliver Wyman in New York and in London. Notable transactions for which Bernhard has been an adviser include Philips on its acquisitions of Biotelemetry and Capsule, GE on its acquisition of BK Medical and spin of GE Healthcare, Abbott on its acquisitions of St Jude Medical and Alere, Terumo on its acquisitions of Sequent Medical and Bolton Medical, Immucor on its sale to Werfen, Decipher on its sale to Veracyte, ArcherDx on its sale to Invitae, Brooks Automation on its acquisitions of Genewiz and BioStorage Technologies, among many others.

Dr. Sakmann earned a B.A. and an M.A. in Natural Sciences from Cambridge University, UK. a B.M. BCh. from Oxford University, UK, and a Doctorate in Medicine from Ludwig-Maximilians-University, Munich, Germany.